COMMUNIQUÉS West-GlobeNewswire

-
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
05/02/2025 -
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
05/02/2025 -
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
05/02/2025 -
New Survey from Aeroflow Urology Reveals Lack of Postpartum Incontinence Care Causes Lasting Health Problems for Mothers
05/02/2025 -
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
04/02/2025 -
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
04/02/2025 -
Monthly information on share capital and company voting rights
04/02/2025 -
Conavi Medical Retains BND Projects Inc. for Corporate Development Services
04/02/2025 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/02/2025 -
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/2025 -
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
04/02/2025 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/2025 -
InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024
04/02/2025 -
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/2025 -
Exagen Inc. to Participate in Upcoming Investor Conferences
04/02/2025 -
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
04/02/2025 -
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04/02/2025 -
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04/02/2025 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/2025
Pages